Preliminary efficacy data is truly encouraging, but here’s how we can best understand what it means (and DOESN’T mean).
Here’s a decent NY Times summary.
And here’s a prior video I did on vaccine challenges with Dr. Paul Offit.
Here’s a decent NY Times summary.
And here’s a prior video I did on vaccine challenges with Dr. Paul Offit.